Fresh frozen plasma for moderate-to-severe traumatic brain injury (FIT-BRAIN)
Official title: Multi-institutional Phase 2/3 Trial of Fresh Frozen Plasma (FFP) in Patients With Moderate to Severe Traumatic Brain Injury (TBI)
Run by Northwestern University · NCT06062888 · Data updated 2026-11-12
This trial will try adding two units of fresh frozen plasma to standard care in adults 18–65 with moderate to severe TBI to see if it is safe and improves short- and longer-term brain and functional outcomes.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 357 (estimated) |
| Sponsor | Northwestern University Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | February 1, 2026 |
| Main results expected | August 2028 |
| Study ends | June 2029 |
| Registry record updated | February 11, 2026 |
| Trial ID | NCT06062888 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with moderate to severe TBI (GCS 3–12) and CT findings consistent with BIG 3 who can receive treatment within one hour of hospital arrival are the intended participants.
✕Probably not a fit
People with known plasma reactions, advanced organ failure, severe respiratory disease on home oxygen, class 3 hemorrhagic shock, unknown time of injury, interfacility transfers, current incarceration, inadequate venous access, or judged to have non-survivable injuries are excluded and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized phase 2/3 study assigns adults with moderate-to-severe traumatic brain injury to standard care alone or standard care plus two units (400–500 mL) of fresh frozen plasma (FFP). Treatment must start quickly after hospital arrival and researchers will measure hemorrhagic progression on 24-hour CT, 24-hour Glasgow Coma Scale, Disability Rating Scale, and Extended Glasgow Outcome Scale at 3 and 6 months, along with ICU-free days and mortality. A nested sub-study will collect blood biomarkers and baseline imaging features to identify who is most likely to benefit. The trial is led by a major academic trauma center network with enrollment at participating sites.
Why it matters
Potential benefit: If successful, adding FFP could reduce bleeding progression and improve survival and functional recovery after moderate-to-severe TBI.
How similar studies have gone: While plasma-based resuscitation has evidence in hemorrhagic trauma, randomized data specific to adding FFP for isolated moderate-to-severe TBI are limited, so this application is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female between the ages of 18 and 65 years 2. Moderate to severe TBI: GCS 3-12 3. Cerebral trauma confirmed on the initial CT scan with radiographic findings consistent with Brain Injury Guidelines category 3 (BIG 3). 4. The potential participant's wallet, when present, was examined and no power of attorney related to blood product administration was identified. Exclusion Criteria: 1. Persons with a known history of adverse reaction to plasma products. 2. Persons with a known history of congestive heart failure, renal failure, liver failure, or severe respiratory dysfunction requiring home use of supplemental oxygen. 3. Persons who are currently incarcerated. 4. Persons with inadequate venous access. 5. Treatment cannot start within 1 hour of arrival at the hospital. 6. The time of injury is unknown. 7. Non-survivable injuries in the estimation of the attending trauma and/or neurosurgeon. 8. Interfacility transfers 9. Class 3 hemorrhagic shock 10. Persons with known "do not resuscitate" orders prior to randomization 11. Persons who refuse the administration of blood products 12. Persons with a research "opt out" bracelet 13. Persons who require FFP for any other indication (e.g., reversal of coagulopathy)
Where it's running
-
Northwestern University
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Hasan Alam, MD — Northwestern University
- Study coordinator: Hasan Alam, MD
- Email: Hasan.Alam@nm.org
- Phone: 312-926-4962
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding brain function and cognitive outcomes after traumatic brain injury
This study is trying to see how blood flow and brain health after a serious head injury affect thinking and memory recovery one year later for those who have had a moderate to severe traumatic brain injury.
-
Comparing two group wellness programs for people with brain injuries and their caregivers
This study is testing two different online wellness programs to see if they can help people with brain injuries and Alzheimer's disease, along with their caregivers, feel better and improve their quality of life.
-
Using Biperiden to Prevent Epilepsy After Brain Injury
This study tests if the medication biperiden can help prevent seizures in adults who have had a serious brain injury.
-
Online memory intervention for people with traumatic brain injury
This study tests whether an online memory training program can help people with moderate to severe traumatic brain injury improve their memory and brain health.
-
Understanding cerebral vasospasm in traumatic brain injury with subarachnoid hemorrhage
This study is testing how common and serious blood vessel narrowing in the brain is for adults with moderate to severe traumatic brain injuries and bleeding, to see if better scans can help improve their care.
-
Monitoring intracranial pressure in patients with moderate traumatic brain injury
This study is testing if keeping track of pressure inside the skull can help people with moderate traumatic brain injury in China recover better compared to those who don't have this monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.